期刊文献+

大剂量甲氨喋呤化疗最适解救时间的实验研究 被引量:5

Experimental research on the optimal time of CF treatment in naked mice with osteosarcoma treated with HD-MTX
暂未订购
导出
摘要 目的探讨应用四氢叶酸(CF)解救大剂量甲氨喋呤(HD-MTX)化疗的最适时间。方法建立骨肉瘤裸鼠动物模型,应用HD-MTX腹腔化疗,在化疗后不同时间应用CF解救10次,观察动物体上肿瘤的坏死率及各器官的毒副作用。结果所有实验动物均出现不同程度的食欲减退和尿量减少,应用HD-MTX化疗后12h开始给CF解救,肿瘤坏死率高,不良反应相对较小;24h后给CF其不良反应明显增高;6h前给CF,虽然不良反应明显小,但其疗效也明显降低。结论HD-MTX化疗后12h开始应用CF解毒疗效好,毒副反应小,安全可行。 Objective To investigate the optimal time of CF treatment in naked mice with osteosatcoma treated with high - dose MTX. Methotis A animal tumor model was developed by cultured MG63 cells. After chemotherapy with HD - MTX, CF was given ten times at different time to alleviate adverse reaction. Pathological examination was performed to observe turmor necrosis rates and toxic and side effects in different organs, Results All animals had gastrointestinal side effects. When CF rescue therapy was given twelve hours after the completion of chemotherapy, turmor necrosis rates were higher and the side effects were relatively less; when CF was given after 24 hours, CF side effects significantly increased; when CF was given before 6 hours, the CF was less effective. Conclusion Twelve hours after the completion of chemotherapy is the optimal time for CF rescue therapy with higher efficacy and less toxicity and side effects.
作者 朱夏 吴朝阳
出处 《临床和实验医学杂志》 2006年第12期1894-1895,共2页 Journal of Clinical and Experimental Medicine
基金 福建省教育厅资助项目 项目编号:JB03185
关键词 骨肉瘤 化疗 四氢叶酸 大剂量甲氨喋呤 Osteosarcoma chemotherapy HD - MTX CF
  • 相关文献

参考文献2

二级参考文献14

  • 1Rha S Y,Oncol Rep,1999年,6卷,631页
  • 2Kleinerman E S,J Clin Oncol,1992年,10卷,1310页
  • 3Kaste SC, Pratt CB, Cain AM, et al. Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis:imaging features. Cancer, 1999, 86: 1602-1608.
  • 4Yonemoto T, Tatezaki S, Ishii T, et al. Prognosis of osteosarcoma with pulmonary, metastases at initial presentation is not dismal. Clin Orthop Relat Res. 1998, (349): 194-199.
  • 5Enneking WF, Kagan A. "Skip" metastases in osteosarcoma. Cancer,1975, 36: 2192-2205.
  • 6Wuisman P, Enneking WF. Staging of osteosarcoma with skip metastases. Z Orthop Ihre Grenzgeb, 1990, 128: 457-462.
  • 7Hopper KD, Moser RP Jr, Haseman DB, et al. Osteosarcomatosis.Radiology, 1990, 175: 233-239.
  • 8Goorin AM, Shuster JJ, Baker A, et al. Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study. J Clin Oncol, 1991, 9: 600-605.
  • 9Belli L, Scholl S, Livartowski A, et al. Resection of pulmonary metastases in osteosarcoma: a retrospective analysis of 44 patients.Cancer, 1989, 63: 2546-2550.
  • 10Jaffe N, Smith E, Abelson HT, el al. Osteogenic sarcoma: alterations in the pattern of pulmonary metastases with adjuvant chemotherapy.J Clin Oncol, 1983,1: 251-254.

共引文献11

同被引文献15

  • 1佟术艳.疼痛的护理评估[J].中华护理杂志,1995,30(2):123-125. 被引量:388
  • 2Abrey LE Batchelor TT Ferreri A J Gospodarowicz M Pulczynski EJ Zucca E Smith JR Korfel A Soussain C DeAngelis LM Neuwelt EA O′Neill BP Thiel E Shenkier T Graus F van den Bent M Seymour JF Poortmans P Armitage JO Cavalli F.Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.[J].中国神经肿瘤杂志,2005,3(3):182-182. 被引量:68
  • 3黄慧强,林旭滨.原发性中枢神经系统淋巴瘤诊治进展[J].中国神经肿瘤杂志,2006,4(3):180-186. 被引量:12
  • 4Blay JY,Ongolo2Zogo P,Sebban C,et al.Primary cerebral lymphomas:unsolved issues regarding first2line treatment,follow2up,late neurological toxicity and treatment of relapses.The FNCLCC.French Federation Nationale des Centres de Lutte contre le Cancer[J].Ann Oncol,2000,11(1):39244.
  • 5张建,李卫,胡明军,蔡林波,岑波,朱泳鹏,林涛.29例原发性中枢神经系统淋巴瘤的诊断与治疗[J].中华神经医学杂志,2007,6(10):1008-1011. 被引量:3
  • 6Andersen LS,Hansen EL, Knudsen JB, et a.1 Pmsltively measured red cell folate levels in methotrexate treated patients with rheumatiod arthritis: relation with drawal and side effects[J]. J Rheumata,l 1997, 24(5): 830-837.
  • 7BATCHELOR T, LOEFFLER J S. Primary CNS lymphoma[ Jl. J Clin Oncol, 2006, 24(8) : 1281 - 1288.
  • 8STERN J I, RAIZER J J. Primary central nervous system lympho- ma[ J 1. Expert Rev Neurother, 2005, 5 (6) : 63 - 70.
  • 9刘辉,杨学军,钟跃.大剂量甲氨蝶呤结合放疗治疗原发性中枢神经系统淋巴瘤[J].灭津医药,2010,38(6):467-469.
  • 10NELSON D F, MARTZ K L, BONNER H, et al. Non- Hodgkin's lymphoma of the brain : can high dose, large volume radiation ther- apy improve survival report on a prospective trial by the Radiation Therapy Oncology Group(RTOG) : RTOG 8315[J]. Int J Radiat Oncol Biol Phys, 1992, 23( 1 ) : 9 -17.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部